Health
State of Health Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19
Just Earth News | @justearthnews | 14 Jan 2021, 09:56 pm Print
China COVID-19 Vaccine Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval, reports BBC.
The vaccine is one of the two which the Brazilian government has lined up.
Brazil is one of the worst-hit COVID-19 nations in the world.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response, reports BBC.
More Health
- Polio returns to spotlight in Pakistan: 13-month-old girl tests positive
- Too busy to exercise? Study finds just following this habit for 4 minutes a day could lower your diabetes risk
- Ultra-processed foods may be rewiring children's brains, new study warns
- Microplastics become chemically active in water, raising health concerns: Study
- Struggling with sleep? Samsung Health's latest update promises more personalised guidance
-1791127926.jpg "Image of the day: October 4, 2026")
